A Multi-Center, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Assess the Efficacy, Safety and Tolerability of Oral DFD-29 (minocycline HCl) Extended Release Capsules Compared to Placebo for the Treatment of Inflammatory Lesions of Rosacea over 16 weeks
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 27 Sep 2018
At a glance
- Drugs Minocycline (Primary)
- Indications Rosacea
- Focus Therapeutic Use
- Sponsors Dr Reddys Laboratories
- 20 Sep 2018 Planned End Date changed from 15 Jul 2018 to 30 Dec 2018.
- 20 Sep 2018 Planned primary completion date changed from 15 Jul 2018 to 30 Dec 2018.
- 20 Sep 2018 Status changed from recruiting to active, no longer recruiting.